Flavimax Overview
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Flavimax General Information
Description
Developer of liposomal-antioxidant drugs designed to treat tissue regeneration and gestosis of pregnant women. The company's drugs are used in gynecology, perinatology, and for the prevention of premature birth, enabling patients to get the treatment quickly.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- Ulica Pobedy, 28
- Reutov
- Moscow, 143968
- Russia
+7 8 (000) 000-00-00
Flavimax Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Aug-2019 | Completed | Out of Business | |||
| 1. Early Stage VC | Completed | Startup |